A structural approach to understanding the effect of loss to follow-up on epidemiologic analyses of HIV-infected patients on antiretroviral therapy in.

Slides:



Advertisements
Similar presentations
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Advertisements

Controlling for Time Dependent Confounding Using Marginal Structural Models in the Case of a Continuous Treatment O Wang 1, T McMullan 2 1 Amgen, Thousand.
High rates of survival, virologic suppression and immune reconstitution among patients receiving second-line ART in the Indian national programme B.B.
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Departments of Medicine and Biostatistics
Informative Censoring Addressing Bias in Effect Estimates Due to Study Drop-out Mark van der Laan and Maya Petersen Division of Biostatistics, University.
Development and pilot an automated Pregnancy and Birth Registry Kara Wools-Kaloustian M.D. M.S.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,
Study Design and Measures of Disease Frequency Intermediate Epidemiology.
EVIDENCE BASED MEDICINE
Effects of patient tracing on estimates of lost to follow-up, mortality and retention in antiretroviral therapy programs in low-middle income countries:
Multiple Choice Questions for discussion
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Prevalence The presence (proportion) of disease or condition in a population (generally irrespective of the duration of the disease) Prevalence: Quantifies.
The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
Management and Development for Health (MDH)
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Arnold School of Public Health Health Services, Policy, and Management 1 Drug Treatment Disparities Among African Americans Living with HIV/AIDS Carleen.
High Blood Pressure Increases Mortality Among HIV Seropositive Individuals Without AIDS in Western Kenya Gerald S. Bloomfield 1, Joseph W. Hogan 2, Alfred.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Community-based Adherence Clubs improve outcomes for stable ART patients: Outcomes from Cape Town, South Africa Anna Grimsrud 1, Maia Lesosky 1,2, Cathy.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Outcomes of newly diagnosed HIV- infected patients referred to care after Provider Initiated.
CREATE Biostatistics Core THRio Statistical Considerations Analysis Plan.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Retention in Care among HIV-infected Patients Receiving Antiretroviral Therapy in Africa: Estimation via a Sampling-based Approach Elvin Geng 1, David.
Implementing an Electronic Medical Record System in a Rural HIV Clinic in Uganda Nicholas Musinguzi 1, Elvin H. Geng 2, David R. Bangsberg 3, Nneka I.
Failure to Initiate ART, Loss to Follow-up and Mortality among HIV-infected Patients during the pre-ART period in Uganda Elvin H. Geng 1, Winnie Muyindike.
Supported by: NIAID/NHLBI R24 AI067039, NIAID R21 AI Viremia copy-years: A measure of cumulative HIV burden among patients initiating antiretroviral.
International Epidemiologic Databases to Evaluate AIDS East Africa IeDEA Executive Committee meeting May 4-5, 2010 Zanzibar Patient retention and losses.
MISSING DATA IN THE INFECTIOUS DISEASES INSTITUTE CLINIC DATABASE Agnes N Kiragga East Africa IeDEA investigators’ meeting 4-5 th May 2010 East African.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Are Patients on HAART in Uganda experiencing less treatment failure than earlier anticipated? A case study of Mbarara JCRC HAART Clinic.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
The Immunologic Efficacy of Antiretroviral Therapy for HIV-infected Patients in North America and Africa IeDEA 2010 San Francisco, CA.
Scaling up access to HIV treatment: comparing outcomes among children receiving treatment at mobile and hospital-based HIV clinics in rural Zambia Janneke.
Engagement in Care for HIV-infected Patients in East Africa East Africa International Epidemiologic Databases to Evaluate AIDS Investigator’s Meeting,
Community-Based Adherence Support Associated with Improved Virological Suppression in Adults Receiving ART: Five-Year Outcomes from a South African Multicentre.
Retention in care and connection to care among HIV-infected patients receiving ART n Africa: Estimation via a sampling-based approach Elvin Geng 1, David.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
ICAP Quarterly Master Slide Set July-September 2007.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Mortality during the first year of HAART in HIV-1-infected patients in 7 countries from Latin America and the Caribbean Suely H. Tuboi, MD, PhD On behalf.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Early survival and clinic retention among high risk HIV-infected patients initiating cART in a pilot Express Care system compared to Routine Care in Western.
Earlier treatment and lower mortality in infants Initiating ART at
Is retention on ART underestimated due to patient transfers
Harvard T.H. Chan School of Public Health
BIPAI Network Experience with multi-month prescribing/refills (MMP)
Conclusions & Implications
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Juan Gonzalez Perez AIDS Healthcare Foundation
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Management and Development for Health (MDH)
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Public Health Implications
Presentation transcript:

A structural approach to understanding the effect of loss to follow-up on epidemiologic analyses of HIV-infected patients on antiretroviral therapy in Africa Geng E.H, Bangsberg D.R., Glidden, D.V., Emenyonu, N., Musinguzi N., Neilands, T.B., Metcalfe, J., Christopoulos, K.A., Kigozi, I, Muyindike, W., Deeks, S.G., Bwana, M.B., Yiannoutsos, C.T., Martin J.N., Petersen M.L.

Background High loss to follow-up in cohorts of HIV-infected patients on ART in Africa may lead to bias in epidemiologic analyses. “Traditional” unweighted regression, inverse probability of censor weights (IPCW) and sample based weights – derived from tracking a numerically small but representative sample of patients lost to follow-up in the community – address the potential for bias via different approaches. To date, no formal comparison of these approaches in a single cohort of HIV-infected patients on ART from Africa has been conducted.

Objectives 1.Evaluate sex as an independent predictor of survival via these three approaches. – Sex is an example of an easily and commonly measured characteristic. – In order to understand the predictive value of sex at ART start, we avoided adjusting for potential time-updated mediators of the effect. 2.Use directed acyclic graphs (DAG’s) to represent contextual knowledge about causal relationships in this patient population. 3.Interpret differences in the findings of each analytic approach in light of these causal assumptions.

Methods Patients: Adult starting ART between January 1 st, 2004 and September 30 th, 2007 at Immune Suppression Syndrome Clinic in Mbarara, Uganda. Measurements: Socio-demographic and clinical characteristics obtained during the course of routine care. Analyses: Pooled logistic regression – Unweighted – Inverse probability of censor weighted – Sample weighted All pre-therapy predictors were used in each multivariable analysis to facilitate cross-analysis comparison Discretized time into month intervals and handled as a restricted cubic spline, obtained standard errors with the clustered sandwich estimator.

Patient Pre-therapy Characteristics n=3628 FactorISS Clinic, Mbarara, Uganda Age, years, (median, IQR)* 35 (30-41) Male sex, n(%)1408 (39) Pre-therapy CD4, cells/cc3, (median, IQR) † 117 (48-197) Weight, kg, (median, IQR) ‡ 54 (47-60) WHO stage 4, n (%) € 745 (22) Start year (14) 20051,380 (38) (25) (21) Distance from clinic to residence ¥ 35.4 ( ) * missing in 31, † missing in 1036; ‡ missing in 227, € missing in 1403, ¥ missing in 740

Patient Follow-up Characteristics n=3628 CharacteristicISS Clinic, Mbarara, Uganda Patient observation time, years, median (IQR)1.4 ( ) Total observation time, years5503 Number of follow up visit, n, median (IQR)8 (3-12) Number of CD4+ T cell determinations, median (IQR) 2 (1-4) Number of weight determinations5 (3-7) Number of regimen switches, n (%)154 (4.2) Transfer requests, n (%)192 (5.3) Interval between visits, days, median (IQR)32 (28-62) Number of deaths known to clinic, n (%)57 (1.6) Number of patients lost to follow-up (defined as six months of absence), n (%) 829 (23%)

All Patients, n=3628 Patients who Continue in Care 829 patients LTFU 128 (15%) tracked 111 (87%) vital status ascertained Sample based weight = Sample based weight

UnweightedIPCWSBW Stabilized weights Mean=1.001 SD = Min=0.464 Max=4.955 Weight=7.47 if LTFU & found 1 if under observation 0 if LTFU & not found Weight estimation CD4, body weight, visit frequency, regimen, transfer request All patients weight=1

FactorUnweightedIPCWSBW OR95% CIp-valueOR95% CIp-valueOR95% CIp-value Age, per 10 years Male sex Weight < 40 kg Pretherapy CD4 value <=50ref > Distance from home to clinic, per 10 km Pre-therapy WHO stage ART start year 2004ref Adjusted Effect of Sex on Mortality via Three Analytic Approaches N=3628

Sex Clinical visit Vital status Loss to follow-up (i.e., censor) Pre-therapy CD4 Time updated CD4 1. Sex has an effect on LTFU because men tend to move, travel for work, etc. But deaths among men are more likely to be reported. 2. Deaths effect LTFU because no systematic mechanism –such as a death registry – exists to capture deaths. 3. Clinic visits effect mortality and LTFU because (a) missing visits at ISS clinic leads to deterioration of health unless the patient seeks care elsewhere and (b) patients who stop visits become censored unless they die and the death is reported.

Sex Clinical visit Vital status Loss to follow-up (i.e., censor) Pre-therapy CD4 Time updated CD4 Conditioning on a common effect

Sex Clinical visit Vital status Loss to follow-up (i.e., censor) Pre-therapy CD4 Time updated CD4 c Unweighted: IPCW: if vital status has an effect on censor, CAR fails. SBW: outcomes completely ascertained in the weighted population

FactorUnweightedIPCWSBW OR95% CIp-valueOR95% CIp-valueOR95% CIp-value Age, per 10 years Male sex Weight < 40 kg Pretherapy CD4 value <= > 200 Distance from home to clinic, per 10 km Pre-therapy WHO stage 4 ART start year Adjusted Effect of Sex on Mortality via Three Analytic Approaches N=3628

Conclusions and Implications Structural biases may be present in data with high losses to follow- up that cannot be easily removed in traditional and IPCW analyses. The basis of the structural bias proposed here – death leads to loss to follow-up (i.e., censor) – may be common in resource limited settings where knowledge of deaths relies on informal reporting mechanisms. The information in time updated covariates that can be used to adjust for informative censor through routine care from African HIV cohorts is limited. A sampling based approach can manage the effects of loss to follow-up in this setting.

Acknowledgements! UCSF – Jeffrey Martin – David Glidden – Eric Vittinghoff – Steven Deeks – Diane Havlir Harvard – David Bangsberg Indiana University – Constantin Yiannoutsos – Kara Wools Kaloustian – Paula Braitstein UC Berkeley – Maya Petersen MUST – Hassan Baryahikwa – “The Ascertainer” – Nicholas Musinguzi – Nneka Emenyonu – Mwebesa Bwana – Winnie Muyindike NIH Rosemary McKaig Carlie Williams Melanie Bacon